Sichuan Goldstone Asia Pharmaceutical Inc. (300434.SZ)
CNY 7.57
(0.53%)
CNY 7.57
(0.53%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 272.1 Million CNY | -10.53% |
| 2022 | 382.32 Million CNY | 74.67% |
| 2021 | 180.67 Million CNY | 122.38% |
| 2020 | -572.48 Million CNY | -63.96% |
| 2019 | 242.69 Million CNY | -2.41% |
| 2018 | 275.79 Million CNY | 31.92% |
| 2017 | 211.4 Million CNY | 739.2% |
| 2016 | 32.39 Million CNY | 20.6% |
| 2015 | 29.76 Million CNY | -49.66% |
| 2014 | 39.59 Million CNY | -31.36% |
| 2013 | 59.28 Million CNY | -13.72% |
| 2012 | 68.52 Million CNY | 14.12% |
| 2011 | 60.36 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 21.69 Million CNY | 142.96% |
| 2024 Q1 | 115.88 Million CNY | 105.64% |
| 2024 Q2 | -50.5 Million CNY | -136.23% |
| 2023 Q2 | 7 Million CNY | -96.24% |
| 2023 FY | - CNY | -10.53% |
| 2023 Q4 | 67.79 Million CNY | 435.41% |
| 2023 Q3 | -20.21 Million CNY | -388.56% |
| 2023 Q1 | 186.16 Million CNY | 9.37% |
| 2022 FY | - CNY | 74.67% |
| 2022 Q3 | 26.76 Million CNY | 342.0% |
| 2022 Q2 | 6.05 Million CNY | -92.45% |
| 2022 Q1 | 80.24 Million CNY | 271.98% |
| 2022 Q4 | 170.21 Million CNY | 535.91% |
| 2021 Q3 | 9.01 Million CNY | 309.37% |
| 2021 Q1 | 94.55 Million CNY | 916.49% |
| 2021 Q2 | 2.2 Million CNY | -97.67% |
| 2021 Q4 | 21.57 Million CNY | 139.42% |
| 2021 FY | - CNY | 122.38% |
| 2020 Q2 | -15.44 Million CNY | -160.6% |
| 2020 Q3 | -8.97 Million CNY | 41.9% |
| 2020 Q4 | 9.3 Million CNY | 203.68% |
| 2020 Q1 | 25.48 Million CNY | -73.57% |
| 2020 FY | - CNY | -63.96% |
| 2019 Q2 | 4.46 Million CNY | -93.11% |
| 2019 Q1 | 64.76 Million CNY | -39.34% |
| 2019 FY | - CNY | -2.41% |
| 2019 Q4 | 96.41 Million CNY | 376.06% |
| 2019 Q3 | 20.25 Million CNY | 353.97% |
| 2018 Q3 | 25.24 Million CNY | 429.4% |
| 2018 FY | - CNY | 31.92% |
| 2018 Q4 | 106.76 Million CNY | 322.86% |
| 2018 Q2 | 4.76 Million CNY | -91.62% |
| 2018 Q1 | 56.9 Million CNY | -49.21% |
| 2017 Q1 | -6.8 Million CNY | -218.96% |
| 2017 Q4 | 112.04 Million CNY | 286.92% |
| 2017 Q2 | 27.03 Million CNY | 497.17% |
| 2017 Q3 | 28.95 Million CNY | 7.12% |
| 2017 FY | - CNY | 739.2% |
| 2016 Q4 | 5.72 Million CNY | 37.91% |
| 2016 Q1 | 2.25 Million CNY | 68.99% |
| 2016 Q2 | 9.37 Million CNY | 315.66% |
| 2016 Q3 | 4.14 Million CNY | -55.76% |
| 2016 FY | - CNY | 20.6% |
| 2015 Q3 | 3.34 Million CNY | -23.17% |
| 2015 FY | - CNY | -49.66% |
| 2015 Q4 | 1.33 Million CNY | -60.12% |
| 2015 Q2 | 4.35 Million CNY | -49.31% |
| 2015 Q1 | 8.59 Million CNY | 48.04% |
| 2014 Q2 | 13.01 Million CNY | 28.7% |
| 2014 Q3 | 9.15 Million CNY | -29.63% |
| 2014 Q4 | 5.8 Million CNY | -36.6% |
| 2014 Q1 | 10.11 Million CNY | 0.0% |
| 2014 FY | - CNY | -31.36% |
| 2013 FY | - CNY | -13.72% |
| 2012 FY | - CNY | 14.12% |
| 2011 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| China National Complete Plant Import & Export Corporation Limited | -372.63 Million CNY | 173.021% |